## Abstract ## Background Cumulative evidence implicates the epidermal growth factor receptor (EGFR) as an important therapeutic target in head and neck squamous cell carcinoma (HNSCC). The basis for the lack of correlation between EGFR expression in the HNSCC tumor and clinical responses to EGFR
The interaction of epidermal growth factor and radiation in human head and neck squamous cell carcinoma cell lines with vastly different radiosensitivities
β Scribed by James A. Bonner; Nita J. Maihle; Beth R. Folven; Teresa J.H. Christianson; Kristen spain
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 567 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0360-3016
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Abstract The degree of gene amplification for epidermal growth factor receptor (EGFR) and its expression levels were examined in 4 cases of tumor lesions and their cell lines of human squamous cell carcinoma (SCC) of the oral cavity. The amplification was detected in 1 case (ZA), but not signifi
Numerous reports have shown an association between overexpression of the epidermal growth factor receptor (EGFR), and poor prognosis in head and neck squamous cell carcinomas (HNSCC), however, the underlying mechanisms are still unclear. In the present study, we set out to determine whether EGFR exp
## Background: Thymidine phosphorylase (dthdpase) is identical to platelet-derived endothelial cell growth factor (pd-ecgf). dthdpase is known to promote the development of new blood vessels, which are fundamental to tumor growth and metastasis. vascular endothelial growth factor (vegf) is a 34-42
## Abstract ## BACKGROUND The endogenous opioid peptide, [Met^5^]βenkephalin, termed opioid growth factor (OGF), interacts with its receptor (OGFr) to play a role as a constitutively expressed inhibitory growth factor in the proliferation of epithelial cells. This study compared protein and gene e